Nano Covax, Vietnam’s domestically-developed vaccine, has proven to be 90 percent effective against SARS-CoV-2.

With US $10.3 per dose, Nanogen’s Nanocovax, which is about to enter the first phase of human trials in the coming days, will be economically affordable to all Vietnamese citizens.

Nanogen's Nanocovax, a potential COVID-19 vaccine candidate in Vietnam, is entering human trials this week. With qualified researchers, state-of-the-art equipment, Nanogen's vaccine is under prompt development. Below are some insights into its manufacturing factory.